Alnylam Pharmaceuticals
ALNY
#799
Rank
NZ$55.25 B
Marketcap
NZ$412.93
Share price
2.47%
Change (1 day)
-49.82%
Change (1 year)
Alnylam Pharmaceuticals Inc. is a biopharmaceutical company focused on the R&D and commercialization of RNA interference (RNAi) therapeutics for genetically defined diseases.

We have found no stock splits for this company